News Archives

News Archives

Avivagen Announces Strategic Changes to Support Growth in Asia and South America

Addition of Mr. Lesley Nernberg brings technical sales and marketing expertise to Asia expansion efforts Termination of distribution agreement with São Paulo-based Look Chemicals creates opportunity for accelerated adoption of OxC-betaTM Livestock in Brazil Ottawa, ON /Business Wire/ July 22, 2021/ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing …Read More

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Ottawa, ON / Business Wire/ June 11, 2021/ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, announces that it has received approval by the TSX Venture …Read More

Avivagen to Present at LD Micro Conference Presentation on June 10th, at 10:30 A.M. EST

Ottawa, ON / Business Wire/ June 8, 2021 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, announces that it will be virtually presenting at the …Read More

Avivagen Inc. Announces Proposed Extension of Warrants and Grant of Options

Ottawa, ON /Business Wire/ June 7, 2021 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”),a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that it will be requesting approval from the TSX …Read More

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2021

Second Quarter Highlights: • Record 64.5 tonne order for OxC-betaTM Livestock over 18 months • New expansion efforts and customer wins in Central and South America • Launch of first product for human health. Ottawa, ON /Business Wire/ June 2, 2021/ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing …Read More

Avivagen Terminates Exclusive U.S. Sales and Distribution Agreement

• Agreement with CSA Animal Nutrition to be terminated effective immediately • Avivagen to explore new sales and distributions opportunities to capitalize on significant market opportunity in the United States Ottawa, ON / Business Wire/ May 7, 2021 / –/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products …Read More